# Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)

> **NCT03772899** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 20 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Fecal Microbial Transplantation

## Key facts

- **NCT ID:** NCT03772899
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-27
- **Primary completion:** 2021-09-14
- **Final completion:** 2026-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03772899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03772899, "Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03772899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*